相关实验视频

Updated: Jul 6, 2025

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

在帕金森病的实验模型中,Sialyl Lewis X的改变表达

Maria João Nunes¹, Andreia Neves Carvalho¹, Alexandra I Rosa¹

¹Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisbon, Portugal.

Journal of molecular medicine (Berlin, Germany)

|January 10, 2024

概括

帕金森病 (PD) 涉及异常的蛋白质变化. 这项研究发现,在PD模型中,一种特定的糖结构Sialyl Lewis X (sLeX) 增加了脑细胞,可能会影响神经元信号传递和免疫反应.

科学领域:

神经科学是一个神经科学.
葡萄糖生物学葡萄糖生物学
免疫学免疫学免疫学

背景情况:

帕金森病 (PD) 中的神经退行机制尚不清楚.
异常的糖基化,一种蛋白质修饰,与PD病变发生有关.
Sialyl Lewis X (sLeX) 对于细胞识别至关重要,并且在病理条件下被上调.

研究的目的:

在帕金森病模型中研究Sialyl Lewis X (sLeX) 的表达和作用.
探索MPTP诱导的神经退行症对大脑中sLeX呈现的影响.

主要方法:

使用了体内和体外的PD模型,包括小鼠的MPTP治疗.
分析了关键酶的蛋白质表达和mRNA水平,如可转移酶7 (FUT7).
检查了神经元 (包括多巴胺能神经元) 和微质细胞中的sLeX局部.

主要成果:

在小鼠条体中,MPTP治疗激活了与糖化相关的通路.
在皮质和条纹体中观察到sLeX装饰蛋白质的呈现增加,以时间依赖的方式.
证实了FUT7mRNA表达的升级和神经元和微质细胞中sLeX的存在.

结论:

在MPTP诱导的PD模型中,sLeX在脑蛋白的表达增加.
sLeX存在于神经元和微质上,这表明它在PD相关的神经炎症中起作用.
大脑中的sLeX在病理条件下可能会影响神经元信号传递和免疫调节.

关键词:

葡萄糖基酶化是什么? 葡萄糖基酶化是什么这是一个MPTPTPMPTP.帕金森病是帕金森氏症的一种疾病.西阿利尔·易斯XX的情况

更多相关视频

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...